4.2 Article

Functional Consequences of a Tissue-Engineered Myocardial Patch for Cardiac Repair in a Rat Infarct Model

Journal

TISSUE ENGINEERING PART A
Volume 20, Issue 7-8, Pages 1325-1335

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tea.2013.0312

Keywords

-

Funding

  1. Minnesota Partnership for Biotechnology and Medical Genomics
  2. NIH NHLBI grant [HL095077, HL67828, HL114120, HL100407]
  3. GAAN from the Department of Education

Ask authors/readers for more resources

Cell therapies have emerged as a promising treatment for the prevention of heart failure after myocardial infarction (MI). This study evaluated the capacity of an aligned, fibrin-based, stretch-conditioned cardiac patch consisting of either the native population or a cardiomyocyte (CM)-depleted population (i.e., CM+ or CM- patches) of neonatal rat heart cells to ameliorate left ventricular (LV) remodeling in the acute-phase postinfarction in syngeneic, immunocompetent rats. Patches were exposed to 7 days of static culture and 7 days of cyclic stretching prior to implantation. Within 1 week of implantation, both patches became vascularized, and non-CMs began migrating from CM+ patches. By week 4, patches had been remodeled into collagenous tissue, and live, elongated, donor CMs were found within grafted CM+ patches. Significant improvement in cardiac contractile function was seen with the administration of the CM+ patch (ejection fraction increased from 35.1%+/- 4.0% for MI only to 58.8%+/- 7.3% with a CM+ patch, p<0.05) associated with a 77% reduction in infarct size (61.3%+/- 7.9% for MI only, 13.9%+/- 10.8% for CM+ patch, p<0.05), and the elimination of LV free-wall thinning. Decreased infarct size and reduced wall thinning also occurred with the administration of the CM- patch (infarct size 36.9%+/- 10.2%, LV wall thickness: 1058.2 +/- 135.4 mu m for CM- patch, 661.3 +/- 37.4 mu m for MI only, p<0.05), but without improvements in cardiac function. Approximately 36.5% of the transplanted CMs survived at 4 weeks; however, they remained separated and electrically uncoupled from the host myocardium by a layer of CM-free tissue, which suggests that the benefits of CM+ patch transplantation resulted from paracrine mechanisms originating from CMs. Collectively, these observations suggest that the transplantation of CM-containing engineered heart tissue patches can lead to dramatic improvements in cardiac function and remodeling after acute MI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available